Discovery of autophagy-tethering compounds as potent NLRP3 degraders for IBD ImmunotherapyKai Yin, Xianfeng Gu, M. X. Wang et al.|European Journal of Medicinal Chemistry|2024Cited by 15
Design, Synthesis, and Bioevaluation of Novel NLRP3 Inhibitor with IBD Immunotherapy from the Virtual ScreenZiwen Zhang, Xianfeng Gu, Hongyu Wu et al.|Journal of Medicinal Chemistry|2024Cited by 14
PCSK9 Targeted Autophagosome-Tethering Compounds: Design, Synthesis, and Antiatherosclerosis EvaluationHongyu Wu, Xianfeng Gu, Mo Wang et al.|Journal of Medicinal Chemistry|2025Cited by 8